CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma
For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor ...
For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor ...
A picture of co-culture that shows the CAR T-cell clusters attacking the tumor cells (in green). Credit: Puig-Saus laboratory. Scientists ...
In vivo scCRISPR screening of intratumoral CTLs reveals connectivity of co-functional modules and gene programs. a, Schematic of the scCRISPR ...
Graphical abstract. Credit: Molecular Therapy (2023). DOI: 10.1016/j.ymthe.2023.07.015 When Richard O'Neil, Ph.D., joined MUSC Hollings Cancer Center two years ago, ...
Credit: CC0 Public Domain In a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published in Nature, researchers ...
Credit: Unsplash/CC0 Public Domain Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and ...
Scanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIH Nearly 90% of patients with an aggressive subtype ...
Credit: Pixabay/CC0 Public Domain Inhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell ...
Figure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and Aplan A ...